Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DCLT - Was just browsing the DSE website and found this...
http://www.digitalsignageexpo.net/2015/public/Content.aspx?ID=197&sortMenu=101005
Was just browsing the DSE website and found this...
http://www.digitalsignageexpo.net/2015/public/Content.aspx?ID=197&sortMenu=101005
Falling wedge...One of my favorite bottom setups...Had many multibag bounces on these setups...
Huh? In 2013 DCLT had revenues of $630,395.00...The current Market Cap at .0036 = 453k...Less than 1 years revenues, using last years revenues which so far the company has increased revenues each of the first 3 quarters of 2014...
First thing I look at after a chart of a stock is the filings...Take a look under the hood...
http://www.otcmarkets.com/stock/DCLT/filings
Good luck in whatever you decide...
LGBS quietly coming off the bottom
LGBS quietly coming off the bottom
.0026s cut in half
WWIO .0026s hit new HOD
WWIO .0026s starting
WWIO .0026s going
I'm only in with a starter at the moment but looking to add
Very nice b_rich!
WWIO worth a look here imo...0023x.0026
Thanks Armani...WWIO next penny runner? Potential is here, like what I am seeing
I'd like to see if we could get back near .03, was trading there just last Nov, Dec.
Thank you, glad to be here...Nice volume over the past two trading days...Reversal in Progress
WWIO
WWIO .0023x.0026 in with a starter
WWIO picked up a starter
In for a few here
WWIO in for a few
My pick is DCLT at .004
I'm already wishing I had bought at least a few today, will be watching closely
I am having the very worst day in my trading history...haven't lost a single dollar but I am now watching runner number 3 of the day that I was contemplating on entering...I know for a fact if I buy anything now it will probably be seconds before the CEO of whatever company files for an R/S...
What I am simply saying is that if you see me posting about any new entries and your in the stock or thinking about buying it, don't and sell quickly....lmao
Oh and P.S. I don't want to talk anymore about it, thanks...
Chart really does look ready for a move higher...Currently pushing the upper bollie higher, MACD about to cross the zero line and RSI mid 50's leaving all kinds of room above...
What is L2 looking like nowadays
Whatever it is the majority of it has traded above .001...almost half above .0015
I thought they had just raised it, not sure what to think...Could be good, maybe a merger or acquisition...
Oh well, 1 tick flipville for now...
No doubt the faucet needs to be shut off for a bit
Only 4.2 mil left at .0004
SMAA 36 mil bid x 6 mil ask, break of .0005 and 00's should be in play
SMAA - 1 bil A/S - new video game segment to be released in March or April 2015
http://www.otcmarkets.com/financialReportViewer?symbol=SMAA&id=131310
SMAA - 1 bil A/S - new video game segment to be released in March or April 2015
http://www.otcmarkets.com/financialReportViewer?symbol=SMAA&id=131310
Your welcome...I'm keeping this one on radar...Have a lowball bid in for shits today...never know, quick flip and watch...
I would have been interested back in the .0003x.0004....Nice looking chart though...
Do you have any ugly charts, they need luvin too! lol
How's it going Armani?
Not so sure now....Increase to 1.5 bil now...wtf...
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10521735
Now, if for some crazy reason panic brings .0005s or lower into play then we would be crazy not to try a few imo
Last year they filed on the 28th of Febuary, this year that's a Saturday so fins due next business day...Monday March 2nd...90 days from year end....
http://www.otcmarkets.com/stock/HBRM/filings
You should know this by now
HERBORIUM Issues Letter to Shareholders To Address Reverse Stock Rumors
Feb 11, 2015
OTC Disclosure & News Service
-
Fort Lee, New Jersey, USA, Feb. 11, 2015 (GLOBE NEWSWIRE) -- Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company's (a provider of unique, all botanical medicines) CEO and Chairwomen Dr. Agnes P. Olszewski issued the following Letter to Shareholders today to respond to rumors of a pending reverse stock split of Herborium's stock.
Dear Shareholders:
We have been receiving numerous inquiries from our shareholders and others, about whether Herborium Group, Inc. is planning to undertake a reverse stock split of our outstanding securities. To dispel such rumors and clarify our position to all interested parties, we wish to inform you that we have no current plans, arrangements, contracts or understandings to undertake a reverse stock split. When and if our board of directors determines to take any material corporate actions we would undertake any such programs in full compliance with all applicable disclosure rules and in accordance with good corporate governance standards, with a focus on the best interests of the Company and its shareholders.
During the past several months, the Company has undertook a number of important initiatives and experienced a number of successful events and developments. We have systematically reported these milestones to our shareholders and the public, sharing our excitement about Herborium's growth and forthcoming opportunities. We will continue doing so as well as reconfirming our commitment to innovative work in a high demand, high growth sector of Botanical Therapeutics®.
Sincerely,
_________________________________
Dr. Agnes P. Olszewski Ph.D. MBA
Chairwomen & CEO
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
CONTACT: Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com
Herborium Group, Inc.
Copyright © 2015 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.